OpenLobby.EU

Drugs for Neglected Diseases initiative

DNDi

Founded in 2003 to address the needs of patients with the most neglected diseases, DNDi is a collaborative, patients’ needs-driven, not-for-profit drug RD organization.

Lobbying Activity

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Strategy to support medical countermeasures against public health threats

8 May 2025

Meeting with Felix Fernandez-Shaw (Director Directorate-General for International Partnerships) and

1 Apr 2025 · Plenary Feedback round on previously held GGIA Working Group sessions of 9 different thematical groups regarding Latin America and the Caribbean (LAC).

Meeting with Laurent Muschel (Acting Director-General Health Emergency Preparedness and Response Authority)

28 Nov 2024 · Development of MCM against climate related health threats

Meeting with Iliana Ivanova (Commissioner) and

22 Apr 2024 · Support of the European Framework Programme for health research and innovation

Meeting with Helmut Scholz (Member of the European Parliament, Rapporteur) and

4 Oct 2023 · Compulsory licenses

Meeting with Sandra Gallina (Director-General Health and Food Safety)

1 Jul 2022 · Conversation with DNDi and GARDP on possible collaboration for DG Santé

Meeting with Jean-Eric Paquet (Director-General Research and Innovation)

14 Jan 2022 · HERA